Warning: The NCBI web site requires JavaScript to function. more...
Kennedy Institute of Rheumatology Division, Imperial College, 1 Aspenlea Road, Hammersmith, London W6 8LH, UK. m.feldmann@imperial.ac.uk
The development of anti-TNF therapy is a key step forward in rheumatology as it is the first new therapy for based on investigating the molecular mechanisms of this disease. This chapter reviews how this discovery was made.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on